Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has informed that the Company (including its subsidiaries and/or associate companies), has entered into an agreement to acquire 85.1% of JSC Biosintez, a Russian pharmaceutical company engaged in manufacture and marketing of pharmaceutical products in Russia and CIS region.

The above information is a part of company’s filings submitted to BSE.